Literature DB >> 25772092

Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2).

Julia Vavken1, Alexander Mameghani2, Patrick Vavken3,4, Stefan Schaeren2.   

Abstract

PURPOSE: To quantitatively synthesize the available best evidence for general complications, heterotopic ossification (HO), retrograde ejaculation, cervical swelling, and cancer rates with the use of rhBMP-2 in lumbar and cervical spine fusion.
METHODS: We conducted an online search for relevant controlled trials and extracted data on the abovementioned endpoints. Studies were eligible for inclusion if they reported on spinal fusion with rhBMP-2 in humans. Publication bias and heterogeneity were assessed mathematically. These data were synthesized in a meta-analysis using DerSimonian-Laird random effects modeling to calculate pooled odds ratios.
RESULTS: We identified 26 studies reporting on a total of 184,324 patients (28,815 experimental, 155,509 controls) with a mean age of 51.1 ± 1.8 years. There was a significantly higher risk of general complications with rhBMP-2 compared to iliac crest bone graft (ICBG) with an odds ratio (OR) of 1.78 (95 %CI 1.20-2.63), (p = 0.004). The odds ratio for HO was 5.57 (95 %CI 1.90-16.36), (p = 0.002), for retrograde ejaculation 3.31 (95 %CI 1.20-9.09), (p = 0.020), and for cervical swelling 4.72 (95 %CI 1.42-15.67), (p = 0.011), all significantly higher in the rhBMP-2 group. The pooled odds ratio for new onset of tumor was 1.35 (95 %CI 0.93-1.96), which represents no statistically significant difference between the groups (p = 0.111).
CONCLUSION: rhBMP-2 is associated with a higher rate of general complications as well as retrograde ejaculation, HO, and cervical tissue swelling in spine fusion. There is a slightly increased risk of new onset of tumors, however, without statistical significance.

Entities:  

Keywords:  Complications; Fusion; Meta-analysis; Spine; rhBMP2

Mesh:

Substances:

Year:  2015        PMID: 25772092     DOI: 10.1007/s00586-015-3870-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  58 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

Authors:  Joseph D Smucker; John M Rhee; Kern Singh; S Tim Yoon; John G Heller
Journal:  Spine (Phila Pa 1976)       Date:  2006-11-15       Impact factor: 3.468

3.  Moving forward after YODA.

Authors:  Bradley K Weiner; Eric L Hurwitz; Mark L Schoene; Eugene J Carragee
Journal:  Spine J       Date:  2013-09       Impact factor: 4.166

4.  Administration of human recombinant bone morphogenetic protein-2 for spine fusion may be associated with transient postoperative renal insufficiency.

Authors:  Jonathan M Latzman; Li Kong; Chuanju Liu; Uzma Samadani
Journal:  Spine (Phila Pa 1976)       Date:  2010-04-01       Impact factor: 3.468

5.  Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.

Authors:  Garet C Comer; Micah W Smith; Eric L Hurwitz; Kyle A Mitsunaga; Robert Kessler; Eugene J Carragee
Journal:  Spine J       Date:  2012-10-22       Impact factor: 4.166

6.  Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?

Authors:  Girish K Hiremath; Michael P Steinmetz; Ajit A Krishnaney
Journal:  Spine (Phila Pa 1976)       Date:  2009-04-20       Impact factor: 3.468

7.  Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.

Authors:  John R Dimar; Steven D Glassman; J Kenneth Burkus; Philip W Pryor; James W Hardacker; Leah Y Carreon
Journal:  J Bone Joint Surg Am       Date:  2009-06       Impact factor: 5.284

8.  Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion.

Authors:  Glenn Robin Buttermann
Journal:  Spine J       Date:  2007-03-07       Impact factor: 4.166

9.  Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.

Authors:  J Kenneth Burkus; Randall F Dryer; John H Peloza
Journal:  J Neurosurg Spine       Date:  2012-11-30

10.  Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2).

Authors:  Gregory S Cooper; Tzuyung Doug Kou
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-01       Impact factor: 3.468

View more
  9 in total

1.  Anatomic feasibility of a new endopelvic approach for iliac crest bone harvesting.

Authors:  S Le Pape; L Du Pouget; T Cloche; M Campana; I Obeid; L Boissiere; J-M Vital
Journal:  Surg Radiol Anat       Date:  2016-05-09       Impact factor: 1.246

2.  Preliminary Results of Bioactive Amniotic Suspension with Allograft for Achieving One and Two-Level Lumbar Interbody Fusion.

Authors:  Pierce D Nunley; Eubulus J Kerr; Philip A Utter; David A Cavanaugh; Kelly A Frank; Devan Moody; Brian McManus; Marcus B Stone
Journal:  Int J Spine Surg       Date:  2016-04-18

3.  Bio-augmented spinal fusion-the best is yet to come.

Authors:  Julia Vavken
Journal:  J Spine Surg       Date:  2016-12

4.  Instrumented Spinal Stabilization without Fusion for Spinal Metastatic Disease.

Authors:  Dori Drakhshandeh; James A Miller; Andrew J Fabiano
Journal:  World Neurosurg       Date:  2017-12-21       Impact factor: 2.104

5.  Bone morphogenetic protein in adult spinal deformity surgery: a meta-analysis.

Authors:  Gregory W Poorman; Cyrus M Jalai; Anthony Boniello; Nancy Worley; Shearwood McClelland; Peter G Passias
Journal:  Eur Spine J       Date:  2017-03-09       Impact factor: 3.134

Review 6.  [Pseudarthrosis and construct failure after lumbar pedicle subtraction osteotomy : Influence of biomechanics, surgical technique, biology and avoidance strategies].

Authors:  C Birkenmaier
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

7.  Risk of Cancer Following Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2): An Analysis Using a Commercially Insured Patient Population.

Authors:  Gregory S Cooper; Tzuyung Doug Kou
Journal:  Int J Spine Surg       Date:  2018-08-03

8.  Sustained zinc release in cooperation with CaP scaffold promoted bone regeneration via directing stem cell fate and triggering a pro-healing immune stimuli.

Authors:  Xin Huang; Donghua Huang; Ting Zhu; Xiaohua Yu; Kaicheng Xu; Hengyuan Li; Hao Qu; Zhiyuan Zhou; Kui Cheng; Wenjian Wen; Zhaoming Ye
Journal:  J Nanobiotechnology       Date:  2021-07-12       Impact factor: 10.435

Review 9.  Biomaterial-based endochondral bone regeneration: a shift from traditional tissue engineering paradigms to developmentally inspired strategies.

Authors:  E J Sheehy; D J Kelly; F J O'Brien
Journal:  Mater Today Bio       Date:  2019-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.